Venker Eric

President &Immunovant CEO | President &COO | Chief Operating Officer

1 company

Weak

Trades Analyzed

12M Win Rate

17.5%

Avg 3M Return

-12.1%

Avg 12M Return

-39.7%

Venker Eric is a President &Immunovant CEO at Roivant Sciences Ltd.. Recent SEC Form 4 filings include 0 buys and 19 sells.

Estimated insider holdings value: $47.1M based on current market prices.

Holdings by Company

ROIVApr 20, 2026

Current Shares1.65M

Value$47.05M

Net Activity-12,577,626

Bought: 0Sold: 12.58M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 20, 2026	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	200,000	$29.59	$5,918,000.00	-10.8%	-	-
Jan 12, 2026	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	200,000	$21.92	$4,384,000.00	-10.8%	+27.3%	-
Dec 24, 2025	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	275,000	$22.47	$6,179,750.00	-7.8%	+19.4%	-
Dec 9, 2025	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	200,000	$20.85	$4,170,000.00	-11.8%	+44.5%	-
Nov 7, 2025	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	200,000	$20.22	$4,044,000.00	-11.7%	+2.5%	-
Oct 17, 2025	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	851,383	$16.99	$14,467,502.37	-15.9%	+35.0%	-
Oct 13, 2025	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	125,667	$16.29	$2,047,335.75	-4.0%	+36.7%	-
Oct 8, 2025	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	665,159	$16.21	$10,781,813.19	-12.8%	+34.8%	-
Sep 23, 2025	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	1,711,000	$14.92	$25,524,777.28	-18.0%	+53.9%	-
Aug 20, 2025	ROIV Roivant Sciences Ltd.	President &Immunovant CEO	Sale+OE	100,000	$11.72	$1,172,000.00	-5.7%	+75.1%	-